Clinical Trial Update: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1-1b clinical trial is evaluating the safety, preliminary efficacy, and dosimetry of study drug A9-3408 in patients with metastatic melanoma, metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Mucosal Melanoma
• Uveal Melanoma

Drugs mentioned

• A9-3408

Snippet

Sponsor: Alpha-9 Oncology USA Inc. | Conditions: Melanoma Metastatic, Uveal Melanoma, Metastatic | Phase 1 | Status: RECRUITING